Background/Aim: Podocalyxin, a member of the CD34 family of cell surface sialomucins, is
overexpressed in human embryonal carcinoma cell lines, as well as in several cancer types …

Podocalyxin (PODXL) is a CD34-related sialomucin and a well-known marker of embryonic
stem cells. PODXL is expressed in many types of tumors including colorectal cancers, breast …

Simple Summary Malignancies derived from epithelial cells account for over 90% of all
human cancers. Several aspects of cancer progression such as metastasis, immune …

Podocalyxin (Podxl) is a CD34-related cell surface sialomucin that is normally highly
expressed by adult vascular endothelia and kidney podocytes where it plays a key role in …

Aim of the Study Podocalyxin-like 1 is a transmembrane glyco-protein whose
overexpression associates in many cancers with poor prognosis and unfavorable …

Podocalyxin is an anti-adhesive mucin-like transmembrane sialoglycoprotein that has been
implicated in the development of aggressive forms of cancer. Podocalyxin is also known as …

Although their functions in tumour development and progression are not well understood,
several secreted and membrane-associated mucins have proven to be valuable diagnostic …

Introduction Podocalyxin (gene name PODXL) is a CD34-related sialomucin implicated in
the regulation of cell adhesion, migration and polarity. Upregulated expression of …

We have previously identified the cell adhesion protein podocalyxin expressed in a human
pluripotent stem cell, embryonal carcinoma (EC), which is a malignant germ cell …

Podocalyxin (PODXL) overexpression is associated with poor clinical outcomes in various
tumors. PODXL is involved in tumor malignant progression through the promotion of …